STING1 and cancer: Additionally, a biomimetic cancer-cell-membrane-coated nanovaccine delivery system (PLGA/STING@EPBM) effectively delivered STING agonists and tumor antigens to Clec9a+ DCs, showing significant antitumor synergy with radiotherapy [33].